Health Catalyst, Inc. (HCAT) stock
HCATNasdaqServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3075% below fair value
$1.29−0.08 (-5.84%)
Close on Nov 18, 2026Market cap $97.08MP/E –Yield –
Health Catalyst operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Health Catalyst's operating income for the twelve months ending Jun 30, 2026 was -$246.55M. For fiscal 2025 it was -$160.85M. The highest annual figure on record is -$45.54M in fiscal 2017.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$160.85M | – |
| FY2024 | Dec 31, 2024 | -$69.81M | – |
| FY2023 | Dec 31, 2023 | -$126.90M | – |
| FY2022 | Dec 31, 2022 | -$140.01M | – |
| FY2021 | Dec 31, 2021 | -$143.65M | – |
| FY2020 | Dec 31, 2020 | -$96.13M | – |
| FY2019 | Dec 31, 2019 | -$54.87M | – |
| FY2018 | Dec 31, 2018 | -$60.10M | – |
| FY2017 | Dec 31, 2017 | -$45.54M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$36.48M | – |
| Q1 FY2026 | Mar 31, 2026 | -$106.48M | – |
| Q4 FY2025 | Dec 31, 2025 | -$86.08M | – |
| Q3 FY2025 | Sep 30, 2025 | -$17.51M | – |
| Q2 FY2025 | Jun 30, 2025 | -$37.09M | – |
| Q1 FY2025 | Mar 31, 2025 | -$20.17M | – |
| Q4 FY2024 | Dec 31, 2024 | -$17.50M | – |
| Q3 FY2024 | Sep 30, 2024 | -$13.69M | – |
| Q2 FY2024 | Jun 30, 2024 | -$15.81M | – |
| Q1 FY2024 | Mar 31, 2024 | -$22.81M | – |
| Q4 FY2023 | Dec 31, 2023 | -$32.79M | – |
| Q3 FY2023 | Sep 30, 2023 | -$24.58M | – |
| Q2 FY2023 | Jun 30, 2023 | -$34.62M | – |
| Q1 FY2023 | Mar 31, 2023 | -$34.91M | – |
| Q4 FY2022 | Dec 31, 2022 | -$36.75M | – |
| Q3 FY2022 | Sep 30, 2022 | -$45.72M | – |
| Q2 FY2022 | Jun 30, 2022 | -$33.19M | – |
| Q1 FY2022 | Mar 31, 2022 | -$24.35M | – |
| Q4 FY2021 | Dec 31, 2021 | -$44.77M | – |
| Q3 FY2021 | Sep 30, 2021 | -$42.25M | – |
| Q2 FY2021 | Jun 30, 2021 | -$32.32M | – |
| Q1 FY2021 | Mar 31, 2021 | -$24.32M | – |
| Q4 FY2020 | Dec 31, 2020 | -$38.92M | – |
| Q3 FY2020 | Sep 30, 2020 | -$23.46M | – |
| Q2 FY2020 | Jun 30, 2020 | -$15.64M | – |
| Q1 FY2020 | Mar 31, 2020 | -$18.11M | – |
| Q4 FY2019 | Dec 31, 2019 | -$13.67M | – |
| Q3 FY2019 | Sep 30, 2019 | -$20.74M | – |
| Q2 FY2019 | Jun 30, 2019 | -$9.36M | – |
| Q1 FY2019 | Mar 31, 2019 | -$11.09M | – |
| Q4 FY2018 | Dec 31, 2018 | -$12.93M | – |
| Q3 FY2018 | Sep 30, 2018 | -$16.50M | – |
| Q2 FY2018 | Jun 30, 2018 | -$18.81M | – |
See a number that looks wrong?